Alzchem Group (ACT.DE) stock: key figures, P/E, revenue and dividend
Materials · Germany · ISIN DE000A2YNT30
Alzchem Group financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 554.00 m EUR | 562.00 m EUR |
| Gross profit | 163.00 m EUR | 177.00 m EUR |
| Operating income | 74.95 m EUR | 89.84 m EUR |
| EBIT | 81.00 m EUR | 84.00 m EUR |
| Net income | 54.00 m EUR | 63.00 m EUR |
| Diluted EPS – continuing operations | 5.33 EUR | 6.28 EUR |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Alzchem Group
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silicon nitride for ceramics; and photovoltaic modules in the solar industry. The Basics & Intermediates segment produces raw materials for specialty chemicals; and products for agriculture and metallurgy, as well as intermediates for the chemical industry that are produced from lime, carbon, and electricity. This segment also engages in the production and sale of guanidine salts as a raw material for agrochemicals and active pharmaceutical ingredients. The Other & Holding segment provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. It offers products and services to agricultural sector under the CALCIUM CYANAMIDE PERLKA, EMINEX, DORMEX, ALZOGUR, SITOFEX, and BREAK-THRU brands; animal nutrition sector under the CREAMINO brands; human nutrition sector under the CREAPURE, CREAVITALIS, LIVADUR, and ALIPURE brands; pharma sector under the GUANIDINE SALTS BIOSELECT brand; fine chemicals sector under the GUANIDINSALZE -BIOSELECT, CYANAMIDE, DICYANDIAMIDE, GUANAMINE, NITRILES, MELFLOCK and ALZOFIX, THIOUREA, and NITROGUANIDINE brands; metallurgy sector under the CAD, CALCIPRO, and CALZOT brands, as well as technical gases and calcium carbide; renewable energy sector under the DYHARD and SILZOT brands; and custom synthesis, such as toll micronization and manufacturing. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.
More stocks
- Guangdong Alpha Animation and Culture Co Ltd (002292.SZ)
- Neuren Pharmaceuticals Ltd (NEU.AX)
- WEIS MARKETS INC (WMK)
- Tri Continental Closed Fund (TY)
- BWP Trust (BWP.AX)
- Ruentex Industries Ltd (2915.TW)
- Gestamp Automocion SA (GEST.MC)
- Sichuan Swellfun Co Ltd (600779.SS)
- Advanced Echem Materials Company Limited (4749.TWO)
- Greatek Electronics Inc (2441.TW)
- HC Semitek Corp (300323.SZ)
- Beijing Teamsun Technology Co Ltd (600410.SS)
Not investment advice. All data without warranty, price as of 27.10.2026. Details in the risk notice.